ArticleBMC public health2025
Malaria prophylaxis stock-outs and birth- and maternal outcomes in Zimbabwe.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Malaria Elimination in Suriname, Timor-Leste and Georgia: Strategic Lessons for Sub-Saharan Africa.Journal of tropical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundPreventing malaria is crucial, especially given that vulnerable groups such as pregnant women and neonates bear a disproportionate malaria burden and such illness can have long-term consequences for their health. Zimbabwe faces a high burden of malaria, which falls heavily on pregnant women and their neonates, contributing towards maternal and neonatal mortality, maternal anaemia and low birthweight. We contribute to the existing literature by examining the correlation between malaria prophylaxis stock-outs and health outcomes in this vulnerable group in Zimbabwe. Women who do not receive malaria prophylaxis during pregnancy are at risk of malaria infections, which can lead to maternal anaemia and lower birthweight.
methodsOur data set combines the administrative data on malaria prophylaxis stock-outs from 2011 to 2015 accessed from the Ministry of Health and Child Care and the 2015 nationally representative Zimbabwe Demographic and Health Survey data. We estimate the correlation between malaria prophylaxis stock-outs and health outcomes using ordinary least squares and recentered influence functional unconditional quantile regressions analysis.
resultsWe found that malaria prophylaxis stock-outs increase over time and have a significant association with birthweight for neonates at the 50th percentile. For neonates with an average birthweight we see a significant and negative association between stock-outs and birthweight (coefficient: -0.271, 95%CI: -0.496;-0.046). However, stock-outs were insignificantly associated with low birthweight ranges as well as above normal birthweight. Although SP stock-outs were not associated with neonates with low birth weight, they push foetus with average weight towards the lower end of normal birth weight. These neonates are prone to developmental disabilities.
conclusionIt is crucial to ensure the availability of Sulphadoxine/pyrimethamine drugs at the facility level. We recommend that policymakers invest in pharmaceutical information systems and stock ordering systems to prioritise malaria prevention and ensure frequent availability of malaria prophylaxis in Zimbabwe. On the demand-side, more frequent facility visits can also help to ensure adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.